Who Should Report an Error?
Learn who should report a medication error.
Learn More“Direct-to-consumer” medicine ads: Be cautious
If you watch television, flip through magazines or newspapers, surf online, or listen to the radio, you are probably familiar with “direct-to-consumer” advertisements (ads) for prescription medicines. The US and New Zealand are the only two developed countries that allow drug companies to advertise prescription medicines directly to the public. These ads are popular with new medicines that treat chronic conditions such as diabetes and insomnia. In fact, 8 of the top 10 selling medicines in the US currently broadcast or publish at least one “direct-to-consumer” ad portraying happy and satisfied patients. It’s a big business, with drug companies spending an estimated $6.5 billion on “direct-to-consumer” ads in 2016 alone.
Learn MoreAs approval of medical marijuana spreads state by state, labeling problems have led to errors
Today, 33 states plus the District of Columbia (Washington, DC) have legalized medical marijuana (and 11 states plus DC have legalized recreational use of marijuana). Medical marijuana is different than the street product. With medical marijuana, growers must confirm the products’ contents, so this information can be passed on to dispensaries and patients. However, each state has its own regulations for medical marijuana. This has resulted in a wide variety of medical marijuana products and safety concerns, particularly with the labeling of these products.
Learn More